Dupilumab Effects Against Aeroallergen Challenge

NCT05720325 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Asthma, Allergic

Interventions

DRUG: Dupilumab
OTHER: House Dust Mites (HDM)
OTHER: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]
[object Object]